Skip to main content
← All BillsCivicRadar

Tuesday, July 7, 2026

Free · Stays on your device

VA · HB1214INTRO · 6 COSPONSORS

Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies, limit.

Where it is in the process
Plain-English Summary

Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit. Decreases the cap on the cost-sharing payment that a covered person is required to pay for a covered prescription insulin drug from $50 to $35 for a 30-day supply of the prescription insulin drug and provides such cap is an aggregate cap that applies in situations where the covered person is prescribed more than one insulin drug. The bill also establishes such an aggregate cap of $35 for a 30-day supp…

Source: OpenStates · fetched April 13, 2026

Who it affects
Low-income / working-class

Reduces out-of-pocket costs for insulin and diabetes supplies, making them more affordable.

Person with a disability

Reduces out-of-pocket costs for insulin and diabetes supplies, which are often essential for individuals with diabetes, a common disability.

Medicaid / public insuranceindirect

May indirectly benefit Medicaid recipients by potentially lowering overall healthcare costs or encouraging broader adoption of such caps if this is a state-level initiative that influences Medicaid policy.(low confidence)

AI-extracted
Who This AffectsAI analysis
  • Low-income / working-classdirectModerate impactHigh certainty

    Reduces out-of-pocket costs for insulin and diabetes supplies, making them more affordable.

    Decreases the cap on the cost-sharing payment that a covered person is required to pay for a covered prescription insulin drug from $50 to $35 for a 30-day supply of the prescription insulin drug· Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.
    and provides such cap is an aggregate cap that applies in situations where the covered person is prescribed more than one insulin drug.· Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.
    The bill also establishes such an aggregate cap of $35 for a 30-day supp…· Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.
  • Medicaid / public insuranceindirectMinor impactLow certainty

    May indirectly benefit Medicaid recipients by potentially lowering overall healthcare costs or encouraging broader adoption of such caps if this is a state-level initiative that influences Medicaid policy.

    Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.· Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.
  • Person with a disabilitydirectModerate impactHigh certainty

    Reduces out-of-pocket costs for insulin and diabetes supplies, which are often essential for individuals with diabetes, a common disability.

    Decreases the cap on the cost-sharing payment that a covered person is required to pay for a covered prescription insulin drug from $50 to $35 for a 30-day supply of the prescription insulin drug· Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.
    and provides such cap is an aggregate cap that applies in situations where the covered person is prescribed more than one insulin drug.· Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.
    The bill also establishes such an aggregate cap of $35 for a 30-day supp…· Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.
  • Mental health service userindirectMinor impactLow certainty

    May indirectly benefit individuals with mental health conditions who also have diabetes by reducing financial stress associated with managing their health.

    Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.· Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit.
What the Bill Does
  • Limits the cost-sharing payment for a 30-day supply of prescription insulin drugs to $35.
  • Establishes an aggregate cap for insulin cost-sharing, applying even if a person is prescribed multiple insulin drugs.
  • Extends the $35 aggregate cap to diabetes equipment and supplies for a 30-day supply.
Votes
Read full bill text →↓ Why am I seeing this?

Want updates?

Get notified when VA HB1214 moves stage

Pick a channel below. Every option is opt-in, and we tell you exactly what we store.

Email

Identified

We store your email address and the bill ID. We'll send a confirmation link first; alerts only start after you click it. Every email has a one-click unsubscribe.

Coming soon

  • RSS feed· Atom 1.0 + JSON Feed per bill
  • Bluesky· follow a CivicRadar bot post per status change
  • Telegram· channel or DM via bot
  • Discord· channel webhook
  • WhatsApp· via WhatsApp Business
  • SMS· via Twilio